MedPath

Bronchiectasis: Evaluation of an Educational Intervention

Withdrawn
Conditions
Bronchiectasis
Registration Number
NCT01315626
Lead Sponsor
Hill-Rom
Brief Summary

A study of an educational intervention of primary care practice physicians to assist in the identification of patients who have Bronchiectasis and to assess the effectiveness of the specific didactic educational intervention targeting primary care physicians in the recognition of Bronchiectasis.

Detailed Description

A pilot study will be conducted for the purpose of evaluating an educational intervention (Description in Appendix A). As part of the educational intervention, primary care physician(s) will be trained in the use of an algorithm to guide assessment of patients seen with a respiratory chief complaint, and who have not previously been identified as having a diagnosis of BE. We propose an evaluation of three primary care practice(s) to compare the number of patients identified in three three-month periods as having a diagnosis of BE.

The evaluation periods will be as follows: Period 1) the three-month period immediately following the intervention, Period 2) the three-month period immediately preceding the intervention, Period 3) the three month period starting one year prior to the intervention.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Respiratory is the chief complaint
  2. Patient > 35 years of age
  3. Seen in practice for > 12 months
Exclusion Criteria
  1. Prior diagnosis with bronchiectasis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number / Percent of BE patients18 months

The primary outcome for this study will be the number/proportion of patients that meet entrance criteria that are subsequently diagnosed with bronchiectasis.

Secondary Outcome Measures
NameTimeMethod
HRCT patients18 months

Secondary outcomes are the number/proportion of those subjects that undergo HRCT, and the number/proportion of subjects that are then identified as having Bronchiectasis.

Trial Locations

Locations (1)

Howard Rupard, MD Primary Care Practice

πŸ‡ΊπŸ‡Έ

Shelbyville, Tennessee, United States

Howard Rupard, MD Primary Care Practice
πŸ‡ΊπŸ‡ΈShelbyville, Tennessee, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.